DSS Imagetech expands access to incision-free TULSA-PRO prostate cancer therapy via KIMS Hyderabad

Hyderabad, Oct 22 (UNI) Medical technology provider DSS Imagetech on Thursday highlighted the clinical footprint of the TULSA-PRO system in India, an advanced MRI-guided, incision-free, and radiation-free intervention designed for the targeted ablation of diseased prostate tissue. Manufactured by Canada-based Profound Medical Corp and brought exclusively to India by DSS Imagetech, the platform is currently operational at KIMS Hospitals, Hyderabad-the first and sole healthcare facility in India and South Asia offering the treatment. The US FDA-cleared system combines real-time Magnetic Resonance Imaging (MRI) with robotically driven transurethral ultrasound thermal energy, the company said in a release. Under continuous thermal and…